5 results for "Xiuli Mo"
Showing 1–5 · 0.47 seconds · RSS
-
Journal Article
Clinical evidence of exercise intervention in improving adults with type 2 diabetes mellitus and frailty: a narrative literature review
BackgroundThe global aging process is accelerating with the increasing prevalence of diabetes mellitus in the elderly population. Frailty, a clinical syndrome closely related to age, is particularly prevalent in elderly with type 2 diabetes mellitus (T2DM). Previous studies indicated that some…
-
Journal Article
Recent progress on harm, pathogen classification, control and pathogenic molecular mechanism of anthracnose of oil-tea
Oil tea (Camellia oleifera), mainly used to produce high-quality edible oil, is an important cash crop in China. Anthracnose of oil tea is a considerable factor that limits the yield of tea oil. In order to effectively control the anthracnose of oil tea, researchers have worked hard for many years…
-
Journal Article
Efficacy and safety of AiDi injection in treating primary liver cancer: a systematic review on 70 randomized controlled trials
Abstract AiDi injection (ADI) has been widely used for primary liver cancer (PLC), and numerous clinical trials in China have been conducted to compare the efficacy of ADI with other treatments for PLC. This study aimed to conduct a systematic review and meta-analysis to comprehensively evaluate…
-
Journal Article Full text
The Multifunctions and Future Prospects of Endophytes and Their Metabolites in Plant Disease Management
Endophytes represent a ubiquitous and magical world in plants. Almost all plant species studied by different researchers have been found to harbor one or more endophytes, which protect host plants from pathogen invasion and from adverse environmental conditions. They produce various metabolites…
-
Journal Article
Efficacy and safety of PD-1 inhibitors plus chemotherapy for advanced unresectable gastroesophageal cancer: a systematic review and meta-analysis of phase III randomized controlled trials
ObjectiveThe FDA approval of immune checkpoint inhibitors for advanced gastroesophageal cancer (GEC) independent of programmed death-ligand 1 (PD-L1) expression status has sparked notable clinical controversy, highlighting the urgent need for evidence-based evaluation of the efficacy and safety of…